drugset
drugset / Trial / NCT03358485

Study of Aolanti Weikang Tablets in Healthy Volunteers

NCT03358485 ↗

Phase 1 Completed 24 enrolled Jiangxi Qingfeng Pharmaceutical Co. Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of multiple doses escalation of Aolanti Weikang tablets to determine the MTD in healthy volunteers

Timeline

Start
2017-12-14
Primary completion
2018-04-21
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Aolanti Weikang tablets Traditional medicine (herbal / TCM) 3 unknown Oral
Subject Aolanti Weikang tablets Traditional medicine (herbal / TCM) 6 unknown Oral
Subject Aolanti Weikang tablets Traditional medicine (herbal / TCM) 8 unknown Oral

Indications

dyspepsia